YNIOS Pharma 3A

Equity
€68,500
total amount raised in round
  • Backed by over 50 investors
  • Eligible for a tax reduction
This campaign has been closed

Jean F Plucker

Co-founder

Throughout his career, Jean François has specialized in technology transfers between university or federal laboratories and private industrial companies. His strength lies in combining scientific and economic logic. At YNIOS Pharma, he brings extensive experience in management, international trade, and intellectual property.

Philippe Van Wesepoel

Co-founder

Co-Founder & CSO
With a scientific background and an MBA, Philippe has experience in various therapeutic areas of the pharmaceutical industry, demonstrating both practical sense and scientific rigor. His curiosity and determination allow him to thoroughly explore issues, focusing on improving quality of life. The values and mission of YNIOS PHARMA align well with his own: developing more effective and better-tolerated therapeutic solutions through a new concept that constitutes a disruptive innovation.